Funding for this research was provided by:
Cancer Prevention and Research Institute of Texas (RP1607674)
National Cancer Institute (K05CA135923)
Text and Data Mining valid from 2019-08-05
Received: 2 September 2018
Accepted: 23 July 2019
First Online: 5 August 2019
Ethics approval and consent to participate
: This study was approved by the University of Texas Medical Branch Institutional Review Board and informed consent was not obtained due to the nature of the study. Waiver of consent is was granted under the U.S. Federal Policy for the Protection of Human Subjects 45 CFR 46.116 which states that the nature of the study involves no more than minimal risk to subjects, research could not be carried out practicably without the waiver or alteration, and waiver will not adversely affect the rights and welfare of the subjects.
: Board membership: AHRQ, NIDA, Sunovion, Mylan, Astra Zeneca; Veran Medical consultant.